Cargando…

Local care and treatment of liver disease (LOCATE) – A cluster-randomized feasibility study to discover, assess and manage early liver disease in primary care

BACKGROUND: Chronic liver disease is an escalating problem both in the United Kingdom and worldwide. In the UK mortality rates have risen sharply over the previous 50 years predominantly due to alcohol, however the increasing prevalence of non-alcohol related fatty liver disease both in the UK and e...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Gohary, Magdy, Moore, Mike, Roderick, Paul, Watkins, Emily, Dash, Joanne, Reinson, Tina, Newell, Colin, Kim, Miranda, Stuart, Beth, Becque, Taeko, Sheron, Nick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303066/ https://www.ncbi.nlm.nih.gov/pubmed/30576330 http://dx.doi.org/10.1371/journal.pone.0208798

Ejemplares similares

Healthcare practitioners’ experiences of an intervention to detect and treat patients with liver disease (the LOCATE intervention): a qualitative process evaluation
por: Reinson, Tina, et al.
Publicado: (2019)

Transient elastography in patients at risk of liver fibrosis in primary care: a follow-up study over 54 months
por: Reinson, Tina, et al.
Publicado: (2021)

Can routine blood tests be modelled to detect advanced liver disease in the community: model derivation and validation using UK primary and secondary care data
por: Hydes, Theresa, et al.
Publicado: (2021)

Clustering of continuous and binary outcomes at the general practice level in individually randomised studies in primary care - a review of 10 years of primary care trials
por: Stuart, Beth, et al.
Publicado: (2020)

Are the opportunities to prevent alcohol related liver deaths in the UK in primary or secondary care? A retrospective clinical review and prospective interview study
por: Verrill, Clare, et al.
Publicado: (2006)

Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
por: Reinson, Tina, et al.
Publicado: (2023)

Antibiotic effectiveness for children with lower respiratory infections: prospective cohort and trial in primary care
por: Little, Paul, et al.
Publicado: (2022)

Predicting illness progression for children with lower respiratory infections in primary care: a prospective cohort and observational study
por: Little, Paul, et al.
Publicado: (2023)

Validation of the liver traffic light test as a predictive model for survival and development of liver‐related events
por: Sylvester, Rochelle, et al.
Publicado: (2021)

Performance of the Enhanced Liver Fibrosis Score, Comparison with Vibration-controlled Transient Elastography Data, and Development of a Simple Algorithm to Predict Significant Liver Fibrosis in a Community-based Liver Service: A Retrospective Evaluation
por: Reinson, Tina, et al.
Publicado: (2023)

Hepatocyte Expression of the Senescence Marker p21 Is Linked to Fibrosis and an Adverse Liver-Related Outcome in Alcohol-Related Liver Disease
por: Aravinthan, Aloysious, et al.
Publicado: (2013)

Liver and COVID-19: From care of patients with liver diseases to liver injury
por: Gaspar, Rui, et al.
Publicado: (2021)

Plasma proteome profiling discovers novel proteins associated with non‐alcoholic fatty liver disease
por: Niu, Lili, et al.
Publicado: (2019)

Newly discovered endocrine functions of the liver
por: Rhyu, Jane, et al.
Publicado: (2021)

Methylated Phenylarsenical Metabolites Discovered in Chicken Liver
por: Peng, Hanyong, et al.
Publicado: (2017)

A causal model for longitudinal randomised trials with time-dependent non-compliance
por: Becque, Taeko, et al.
Publicado: (2015)

Impact of COVID-19 pandemic on liver, liver diseases, and liver transplantation programs in intensive care units
por: Omar, Amr Salah, et al.
Publicado: (2021)

Patients’ understanding of cellulitis and their information needs: a mixed-methods study in primary and secondary care
por: Teasdale, Emma, et al.
Publicado: (2019)

The versatility of liver X receptors in T cell homeostasis: Location, location, location!
por: Phan, Truong San, et al.
Publicado: (2021)

Influence of external peer reviewer scores for funding applications on funding board decisions: a retrospective analysis of 1561 reviews
por: Sorrell, Lexy, et al.
Publicado: (2018)

Location, Location, Location: Usual Source of Care, Kidney Disease Outcomes, and the Social Determinants of Health
por: Quinn, Robert R., et al.
Publicado: (2022)

Palliative care for people with advanced liver disease: A feasibility trial of a supportive care liver nurse specialist
por: Kimbell, Barbara, et al.
Publicado: (2018)

Liver Disease and Coronavirus Disease 2019: From Pathogenesis to Clinical Care
por: Saviano, Antonio, et al.
Publicado: (2021)

Prediction of liver disease in patients whose liver function tests have been checked in primary care: model development and validation using population-based observational cohorts
por: McLernon, David J, et al.
Publicado: (2014)

Systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver disease
por: Parkes, Julie, et al.
Publicado: (2012)

Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist()
por: Malik, Adnan, et al.
Publicado: (2019)

Evaluation of work-based screening for early signs of alcohol-related liver disease in hazardous and harmful drinkers: the PrevAIL study
por: Cook, Penny A., et al.
Publicado: (2015)

Overcoming challenges to discover drugs for liver stages of Plasmodium vivax
por: Kyle, Dennis E
Publicado: (2014)

Nonalcoholic Fatty Liver Disease as a Systemic Disease and the Need for Multidisciplinary Care
por: Yoneda, Masato, et al.
Publicado: (2023)

Retrospective Survey of Treatment and Outcomes of COVID-19 in the community
por: Willcox, Merlin, et al.
Publicado: (2021)

Development of a decision support tool to facilitate primary care management of patients with abnormal liver function tests without clinically apparent liver disease [HTA03/38/02]. Abnormal Liver Function Investigations Evaluation (ALFIE)
por: Donnan, Peter T, et al.
Publicado: (2007)

Quality of health care and patient satisfaction in liver disease: The development and preliminary results of the QUOTE-Liver questionnaire
por: Gutteling, Jolie J, et al.
Publicado: (2008)

Acceptability of chronic liver disease screening in a UK primary care setting: a qualitative evaluation
por: Knight, Holly, et al.
Publicado: (2020)

Referral care paths for non‐alcoholic fatty liver disease—Gearing up for an ever more prevalent and severe liver disease
por: van Dijk, Anne‐Marieke, et al.
Publicado: (2021)

Non-pharmaceutical interventions and risk of COVID-19 infection: survey of U.K. public from November 2020 – May 2021
por: Francis, Nick A., et al.
Publicado: (2023)

Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
por: Marjot, Thomas, et al.
Publicado: (2022)

Evaluation of elevated liver values in primary care - a series of studies on the status quo of care in Germany with special reference to alcoholic liver disease
por: Wangler, Julian, et al.
Publicado: (2022)

Intensive care referral and admission: do the criteria for liver disease match?
por: McPeake, J, et al.
Publicado: (2015)

Suggestions for the care of patients with liver disease during the Coronavirus 2019 pandemic
por: Ganne-Carrié, Nathalie, et al.
Publicado: (2020)

Measuring the Quality of Palliative Care for Patients with End-Stage Liver Disease
por: Patel, Arpan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nioictujlqj6kmorf9f2e1apa0